Publications

AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

 31
AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

Tags:

Previous Article

Somatic mutations reveal the ontogeny of human microglia

Next Article

AI designed small molecule inhibitor against pancreatic cancer

Related Posts

Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis

Activity-attenuated serum albumin-fused interleukin-33 ...

 89

How do ramping dynamics influence computations in the entorhinal cortex?

How do ramping dynamics influence computations in the e...

 68

Phenotypic approaches for CNS drugs

Phenotypic approaches for CNS drugs

 122